SE418573B - Sett att framstella ett vaccin - Google Patents

Sett att framstella ett vaccin

Info

Publication number
SE418573B
SE418573B SE7414326A SE7414326A SE418573B SE 418573 B SE418573 B SE 418573B SE 7414326 A SE7414326 A SE 7414326A SE 7414326 A SE7414326 A SE 7414326A SE 418573 B SE418573 B SE 418573B
Authority
SE
Sweden
Prior art keywords
vaccin
make
Prior art date
Application number
SE7414326A
Other languages
English (en)
Other versions
SE7414326L (sv
Inventor
T V Peradze
E A Fridman
N V Zheleznova
V M Kolikov
S K-E Brasler
B V Mchedlishvili
V M Molodkin
L M Molodkina
N V Katushina
Original Assignee
Le Polt I Im M I Kalinina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le Polt I Im M I Kalinina filed Critical Le Polt I Im M I Kalinina
Publication of SE7414326L publication Critical patent/SE7414326L/xx
Publication of SE418573B publication Critical patent/SE418573B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7414326A 1973-11-16 1974-11-14 Sett att framstella ett vaccin SE418573B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU7301967101A SU579309A1 (ru) 1973-11-16 1973-11-16 Способ получени вакцины

Publications (2)

Publication Number Publication Date
SE7414326L SE7414326L (sv) 1975-05-20
SE418573B true SE418573B (sv) 1981-06-15

Family

ID=20566763

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414326A SE418573B (sv) 1973-11-16 1974-11-14 Sett att framstella ett vaccin

Country Status (9)

Country Link
US (1) US4071619A (sv)
CS (1) CS172111B1 (sv)
DD (1) DD114615A1 (sv)
DE (1) DE2452919C3 (sv)
FR (1) FR2251334B1 (sv)
GB (1) GB1446107A (sv)
HU (1) HU175489B (sv)
SE (1) SE418573B (sv)
SU (1) SU579309A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328208A (en) * 1981-05-20 1982-05-04 Kurbanov Ildus A Vaccine against chlamydous infections of farm animals
US4880512A (en) * 1984-02-16 1989-11-14 Kollmorgen Corporation Pulsed light selective photolysis process for treatment of biological media and products made thereby
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS6176160A (ja) * 1984-09-21 1986-04-18 松永　是 殺細胞方法
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
US5639461A (en) * 1994-09-30 1997-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Influenza machine
WO2011130119A2 (en) 2010-04-14 2011-10-20 Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof

Also Published As

Publication number Publication date
SU579309A1 (ru) 1977-11-05
DE2452919C3 (de) 1981-01-22
FR2251334B1 (sv) 1978-07-21
HU175489B (hu) 1980-08-28
DD114615A1 (sv) 1975-08-12
DE2452919B2 (de) 1980-05-22
GB1446107A (en) 1976-08-11
CS172111B1 (sv) 1976-12-29
FR2251334A1 (sv) 1975-06-13
SE7414326L (sv) 1975-05-20
DE2452919A1 (de) 1975-05-22
US4071619A (en) 1978-01-31

Similar Documents

Publication Publication Date Title
SE420405B (sv) Sett att framstella ett polykarboxylatcement
SE389690B (sv) Sett att framstella ett vermeaterhemtbart foremal
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE418671B (sv) Sett att framstella ett proteinhaltigt fodoemne
SE416476B (sv) Sett att framstella ett styvt alster
SE418567B (sv) Sett att framstella ett fast proteinhaltigt fodoemne
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE417089B (sv) Sett att framstella en sulfonamidoarylforening
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE7506313L (sv) Sett att framstella ett prostaglandinkonjugat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE7711154L (sv) Sett att framstella en smorjmedeltillsats
SE418573B (sv) Sett att framstella ett vaccin
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE405525B (sv) Sett att framstella ett halvledaraggregat
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE396428B (sv) Sett att framstella en filterbrunn
SE414179B (sv) Sett att framstella alkylfosfiner
SE427655B (sv) Sett att framstella abietamidderivat
SE389689B (sv) Sett att framstella ett vermeaterhemtbart foremal
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE389145B (sv) Sett att framstella en fiberprodukt
SE428471B (sv) Sett att framstella imidazolderivat